Product Images Montelukast Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Montelukast Sodium NDC 53002-4441 by Rpk Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Image - lbl530024441
Figure1 - montelukast fig1
Figure 1 shows the change in height (in centimeters) from the randomization visit by scheduled week for different treatment groups. The plot includes the treatment group mean and the standard error of the mean. The x-axis represents the weeks on treatment, ranging from 9 to 56. The three treatment groups are Montelukast 5 mg (n=120), Beclomethasone 336 μg (n=119), and the Placebo (n=121). The standard errors of the treatment group means are mentioned to be too small to be visible on the plot.*
Figure2 - montelukast fig2
Figure 2 shows the mean percent change from baseline in FEV (forced expiratory volume) in a U.S. trial comparing Montelukast Sodium to placebo. The trial included 40 participants in the Montelukast Sodium group and 270 participants in the placebo group. The graph displays the data at different weeks in the treatment period and the washout phase. The ANOVA model was used for analysis.*
Chemical Structure - montelukast str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.